Skip to content
★ Sign in to follow
BL

Barry Labinger

Emergent BioSolutions Inc.Human Genome Sciences Inc
Total declarations
38
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€5.9M

Latest filing published 17 Nov 2015 for Emergent BioSolutions Inc., €114k.

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

No signal scores available.

Barry Labinger: trading record in brief

Filings by Barry Labinger span 2 companies, the busiest being Human Genome Sciences Inc and Emergent BioSolutions Inc. The record holds 38 filings, for trades running from 16 August 2006 to 13 November 2015.

Sales make up the whole of the open-market record (15 sales, €5.9M). The rest of the record consists of 6 share grants and 16 option exercises. So far in 2015, the count stands at no purchases and 5 sales.

Most recently, on 17 November 2015, the filings show an open-market sale worth €114k in Emergent BioSolutions Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Barry Labinger

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations38 total

25 of 38 declarations